Literature DB >> 29658929

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis.

Shinichiro Yokota1, Yoshihiro Ono2, Toshimasa Nakao2, Peng Zhang3, George K Michalopoulos4, Zahida Khan5.   

Abstract

In rodents, complete bile duct ligation (cBDL) of the common bile duct is an established surgical technique for studying obstructive cholestasis and bile duct proliferation. However, long-term experiments can lead to increased morbidity and mortality. In select mouse strains with underlying liver disease, meaningful comparisons can be made even with ligation of a single lobe of the liver, which can reduce animal losses and expenses. Here, we describe partial bile duct ligation (pBDL) in the mouse, in which only the left hepatic bile duct is ligated, causing biliary obstruction in the left lobe but not the remaining lobes. With careful microsurgical technique, pBDL experiments can be cost-effective, since the unligated lobe serves as an internal control to the ligated lobes, when subjected to the same conditions in the same animal. Unlike cBDL, a separate sham-operated control group is not necessary. pBDL is highly useful to directly compare localized versus systemic effects of cholestasis and other retained bile components. pBDL can also be repurposed as a novel method to investigate mechanisms related to medications and cell migration.

Entities:  

Mesh:

Year:  2018        PMID: 29658929      PMCID: PMC5933264          DOI: 10.3791/56930

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  22 in total

1.  The common bile duct ligation in rat: A relevant in vivo model to study the role of mechanical stress on cell and matrix behaviour.

Authors:  Christelle Guyot; Chantal Combe; Alexis Desmoulière
Journal:  Histochem Cell Biol       Date:  2006-04-20       Impact factor: 4.304

2.  Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice.

Authors:  J A Carlson; B B Rogers; R N Sifers; M J Finegold; S M Clift; F J DeMayo; D W Bullock; S L Woo
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

3.  Partial bile duct ligation in mice: a novel model of acute cholestasis.

Authors:  Stefan Heinrich; Panco Georgiev; Achim Weber; Athanasios Vergopoulos; Rolf Graf; Pierre-Alain Clavien
Journal:  Surgery       Date:  2011-03       Impact factor: 3.982

4.  Bile Duct Ligation Induces ATZ Globule Clearance in a Mouse Model of α-1 Antitrypsin Deficiency.

Authors:  Zahida Khan; Shinichiro Yokota; Yoshihiro Ono; Aaron W Bell; Michael Oertel; Donna B Stolz; George K Michalopoulos
Journal:  Gene Expr       Date:  2016-08-18

5.  Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency.

Authors:  David A Rudnick; Olga Shikapwashya; Keith Blomenkamp; Jeffrey H Teckman
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

6.  Effect of bile duct ligation on bile acid composition in mouse serum and liver.

Authors:  Youcai Zhang; Ji-Young Hong; Cheryl E Rockwell; Bryan L Copple; Hartmut Jaeschke; Curtis D Klaassen
Journal:  Liver Int       Date:  2011-10-17       Impact factor: 5.828

7.  Antibacterial efficacy of cefazolin and cephradine in neutropenic mice.

Authors:  M W Kunst; H Mattie; R van Furth
Journal:  Infection       Date:  1979       Impact factor: 3.553

8.  A novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagy.

Authors:  Evrim Gurpinar; William E Grizzle; John J Shacka; Burton J Mader; Nan Li; Nicholas A Piazza; Suzanne Russo; Adam B Keeton; Gary A Piazza
Journal:  Mol Cancer Ther       Date:  2013-02-26       Impact factor: 6.261

9.  Identification of intramural epithelial networks linked to peribiliary glands that express progenitor cell markers and proliferate after injury in mice.

Authors:  Frank DiPaola; Pranavkumar Shivakumar; Janet Pfister; Stephanie Walters; Gregg Sabla; Jorge A Bezerra
Journal:  Hepatology       Date:  2013-08-06       Impact factor: 17.425

10.  Factors released from cholestatic rat livers possibly involved in inducing bone marrow hepatic stem cell priming.

Authors:  Jun Xu; Xutao Deng; Achilles A Demetriou; Daniel L Farkas; Thomas Hui; Charles Wang
Journal:  Stem Cells Dev       Date:  2008-02       Impact factor: 3.272

View more
  4 in total

1.  Characterizing Fibrosis and Inflammation in a Partial Bile Duct Ligation Mouse Model by Multiparametric Magnetic Resonance Imaging.

Authors:  Jia-Yi Liu; Ye-Yu Cai; Zhu-Yuan Ding; Zi-Yi Zhou; Min Lv; Huan Liu; Li-Yun Zheng; Lan Li; Yong-Heng Luo; En-Hua Xiao
Journal:  J Magn Reson Imaging       Date:  2021-09-21       Impact factor: 5.119

2.  Gan Shen Fu Fang ameliorates liver fibrosis in vitro and in vivo by inhibiting the inflammatory response and extracellular signal-regulated kinase phosphorylation.

Authors:  Qing-Hong Du; Chu-Jun Zhang; Wei-Hong Li; Yan Mu; Ya Xu; Scott Lowe; Lin Han; Xue Yu; Shu-Yan Wang; Yu Li; Jian Li
Journal:  World J Gastroenterol       Date:  2020-06-07       Impact factor: 5.742

Review 3.  Rodent models of cholestatic liver disease: A practical guide for translational research.

Authors:  Eva Gijbels; Alanah Pieters; Kevin De Muynck; Mathieu Vinken; Lindsey Devisscher
Journal:  Liver Int       Date:  2021-02-23       Impact factor: 5.828

4.  Up-regulation of miR-let7a-5p Leads to Decreased Expression of ABCC2 in Obstructive Cholestasis.

Authors:  Natarajan Balasubramaniyan; Michael W Devereaux; David J Orlicky; Ronald J Sokol; Frederick J Suchy
Journal:  Hepatol Commun       Date:  2019-09-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.